Where can I find the detailed financial results for Gilead Sciences' third quarter of 2017?

The detailed financial results are primarily located in the press release issued by Gilead Sciences on October 26, 2017, which is filed as Exhibit 99.1 to this 8-K report.

Does Gilead provide both GAAP and non-GAAP financial results?

Yes, Gilead Sciences presented its financial results for the quarter on both a U.S. generally accepted accounting principles (GAAP) basis and a non-GAAP basis.

Why does Gilead provide non-GAAP financial information?

Gilead's management believes that non-GAAP financial information is useful for investors because management uses this information internally for operating, budgeting, and financial planning purposes. However, investors should use this non-GAAP information to supplement, not replace, their understanding of Gilead's GAAP financial statements.

Is the financial information in this 8-K report considered 'filed' for legal liability purposes?

No, the information in this Form 8-K and its exhibit is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, meaning it is not subject to the liabilities under that section.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on October 26, 2017, to announce its financial results for the third quarter ended September 30, 2017. The filing primarily references a press release (Exhibit 99.1) which contains the detailed financial outcomes and management's commentary. Investors should review this press release for specific figures related to revenue, earnings, and other key financial metrics for the quarter. The company provided both GAAP and non-GAAP financial measures, noting that management believes the non-GAAP figures offer additional useful insights for investors. A reconciliation between GAAP and non-GAAP results is available within the press release. It is important for investors to understand that non-GAAP measures are not standardized and may be calculated differently by other companies, thus they should be considered supplementary to GAAP financials.

Key Highlights

1Gilead Sciences announced its third-quarter 2017 financial results via an 8-K filing on October 26, 2017.
2The primary information is contained within the press release attached as Exhibit 99.1.
3Financial results for the three and nine months ended September 30, 2017, and 2016, were reported.
4Gilead presented financial information on both a GAAP and non-GAAP basis.
5Management believes non-GAAP financial information provides useful insights for investors.
6A reconciliation between GAAP and non-GAAP figures is included in the press release.
7Information furnished in this report is not considered 'filed' for Section 18 liability purposes.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Oct 26, 2017)

Summary

Key Highlights

Frequently Asked Questions